Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
153.4 USD | +3.27% | +18.22% | -15.11% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.11% | 15.52B | |
-2.39% | 103B | |
+0.89% | 95.71B | |
+2.01% | 22.02B | |
-16.69% | 20.9B | |
-8.98% | 17.85B | |
-42.83% | 16.21B | |
+3.83% | 13.86B | |
+33.23% | 12.04B | |
-26.06% | 8.08B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : SVB Leerink Adjusts BeiGene's Price Target to $417 from $388, Keeps Outperform Rating